文献速递骨肿瘤关节外科

骨关节同种异体骨移植重建在3级骨巨细胞瘤整块切除后的长期生存率

Does Osteoarticular Allograft Reconstruction Achieve Long-term Survivorship after En Bloc Resection of Grade 3 Giant Cell Tumor of Bone?
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

本研究回顾性分析1980至2007年接受整块切除和骨关节同种异体骨移植重建的3级骨巨细胞瘤患者,中位随访26年,10年无移植物移除生存率为85%,无再手术生存率为72%,MSTS评分中位28分,结论认为该重建方式长期生存率优良。

要点

  • 3级骨巨细胞瘤整块切除后骨关节同种异体骨移植重建10年无移除生存率85%。
  • 10年无再手术生存率72%,中位MSTS功能评分28分。
  • 膝关节炎评估中多数为Ahlbäck 4型或3型,但仅20例分析。

核心结论

  • 3级骨巨细胞瘤整块切除后骨关节同种异体骨移植重建显示优良的长期生存率。

研究设计与样本

  • 回顾性分析1980至2007年75例接受整块切除的3级骨巨细胞瘤患者,其中39例(52%)接受骨关节同种异体骨移植重建,中位随访26年(范围10至34年)。

主要发现

  • 10年无移植物移除生存率为85%(95% CI 74至96)。
  • 10年无任何原因再手术生存率为72%(95% CI 59至87)。
  • MSTS评分中位28分(范围19至30)。
  • 膝关节Ahlbäck分级在20例中分析:9例为4型,6例为3型,3例为2型,2例为5型。

临床怎么用

  • 在内假体不可用或费用过高的地区,结果支持使用骨关节同种异体骨移植重建。
  • 需与内假体重建进行头对头多中心试验比较。

局限性

  • 回顾性设计,证据等级为Level IV。
  • 39例中8例(21%)最近5年未随访,但已满10年最低监测期。
  • 膝关节炎评估仅基于20例患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: En bloc resection of benign tumors is only indicated in aggressive lesions with substantial destruction of the affected bone. Few reports have evaluated the long-term outcome of Grade 3 giant cell tumor of bone (GCTB; defined as severe bone destruction and soft tissue extension) treated with en bloc resection and reconstruction with a massive allograft. We recently reported that patients with benign tumors achieved better allograft reconstruction survivorship compared with those treated for a malignant bone tumor. In light of that finding, we wondered whether osteoarticular allografts would be a viable long-term alternative for Grade 3 GCTB, which could be important in some countries because of greater availability and lower costs compared with endoprostheses. QUESTIONS/PURPOSES: We analyzed a group of patients with Grade 3 GCTBs treated with en bloc resection and osteoarticular allograft reconstruction in terms of (1) survivorship free from allograft removal at 10 years; (2) survivorship free from reoperation for any reason at 10 years, (3) functional results as measured by the Musculoskeletal Tumor Society (MSTS) score, (4) assessment of arthrosis at the knee. METHODS: We retrospectively analyzed all patients with a Grade 3 GCTB treated between 1980 and 2007. Only patients treated with en bloc resection and reconstruction with massive osteoarticular allografts were included in the analysis. The indication for osteoarticular reconstruction during that time included severe bone destruction with intraarticular compromise of the tumor, intraarticular fracture because of tumor growth, the presence of inadequate remaining subchondral bone to resist normal loading (for the distal femur or proximal tibia), and the preservation of a soft-tissue component (ligaments or meniscus) for articular stability. During the period, 75 patients were treated with en bloc resection. Patients treated with intralesional curettage (n = 7), reconstruction with an endoprosthesis (n = 2), intercalary arthrodesis (n = 13), or unicondylar reconstruction (n = 14) were excluded. Of the original 75 treated with en bloc resection, 52% (39) were treated with osteoarticular allograft reconstruction, and no patient was lost to follow-up before 2 years or had substantial missing data. However, of the 39 patients, another 21% (8) have not been seen in the last 5 years, but these were included here because they reached the 10-year minimum surveillance period before being lost. Twenty-three of those 39 patients were previously reported by our group and 16 new patients (treated between 1980-1985) were included in this series (eight distal radius, six distal femur, two proximal tibias), extending the follow-up period and including more patients for analysis. The median (range) follow-up duration was 26 years (10 to 34). We assessed survivorship using a Kaplan-Meier analysis, we drew MSTS scores retrospectively from patients´ medical records, and we graded arthrosis using the Ahlbäck scale for the knee (which was by far the most common joint involved, n = 31, and so it was the joint we assessed for the presence of arthrosis). RESULTS: The survivorship free from allograft removal was 85% at 10 years (95% CI 74 to 96). The allograft survivorship free from reoperation for any reason at 10 years was 72% (95% CI 59 to 87). The median (range) MSTS score was 28 points (19 to 30). The grade of arthrosis in the knee at last follow-up was analyzed in 20 patients and classified in nine as Ahlbäck Type 4, in six as Type 3, in three as Type 2 and in two as Type 5. CONCLUSIONS: Osteoarticular allograft reconstruction after a Grade 3 GCTB en bloc resection showed excellent long-term survivorship. We believe these results compare favorably with other studies on endoprosthetic reconstruction and head-to-head studies of these approaches should be performed; these would need to be multicenter trials. In the meantime, in locations where endoprostheses are unavailable or too expensive, we believe our results support the use of osteoarticular allografts. LEVEL OF EVIDENCE: Level IV, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Albergo JI, Farfalli GL, Cabas-Geat A, et al. Does Osteoarticular Allograft Reconstruction Achieve Long-term Survivorship after En Bloc Resection of Grade 3 Giant Cell Tumor of Bone? Clin Orthop Relat Res. 2020. PMID: 32469488. doi:10.1097/CORR.0000000000001337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。